Search Results for "Mabvax Pharmaceuticals"
Original Source: MabVax Therapeutics Inc.
MabVax was formed to commercialize the work of Dr. Phil Livingston and colleagues at Memorial Sloan-Kettering Cancer Center (MSKCC) who over the last 25 years have developed monovalent cancer vaccines against ten distinct antigenic targets on various types of cancer cells. These vaccines target gangliosides and other carbohydrate antigens that are the most extensively expressed antigenic targets on the cell surface of certain cancers. Vaccines, or passively administered antibodies developed from these...
Matching Channels
None
Matching News
[MabVax] gets $5.25mm in first Series B tranche
[MabVax Therapeutics Inc.] (antibody vaccines and therapies for cancer) raised $5.25mm through the first closing of its Series B round. Numoda Capital Innovations led, joined by returning backers Burr...
MabVax completes venture financing
NCI Grants MabVax $150K for Neuroblastoma Vaccine
SAN DIEGO, Dec. 18, 2012 /PRNewswire/ -- MabVax Therapeutics Inc., a privately held clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address t...
MabVax Therapeutics, Inc.: Series B $5.3M
MabVax Therapeutics (San Diego, CA), a clinical-stage biotechnology company focused on cancer immunotherapies, closed a $5.3M Series B financing. Participants include Numoda Capital Innovations, Burri...
SAN DIEGO, Nov. 20, 2012 /PRNewswire/ -- MabVax Therapeutics, Inc., a privately held clinical stage biotechnology company focused on the development of proprietary immunotherapies to address the unmet...
BIO Announces Presenting Companies for 11th Annual BIO Investor Forum
The Biotechnology Industry Organization (BIO) announces the initial list of presenting companies for the 11th Annual BIO Investor Forum, an international investor forum which...
There's A Financings of the Fortnight In Every Crowd
"Psst, wanna buy some biotech?"It’s already helped rock singers and indie film makers and arapaima trackers. But can crowdfunding help fill the life sciences venture gap?The JOBS Act of 2012, signed...
Matching PubMed Articles
None
